Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward G D Tuddenham

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|March 18, 2006
Ways to bypass a blocked tenase complexEdward G D Tuddenham
Blood|September 24, 2008
Killing 2 birds with 1 stoneEdward G D Tuddenham
British Journal of Haematology|January 5, 2020
Factor VIII: the protein, cloning its gene, synthetic factor and now - 35 years later - gene therapy; what happened in between?Gavin Ling, Edward G D Tuddenham
Journal of Viral Hepatitis|April 12, 2024
The complex, confusing and poorly understood immune responses to AAV-mediated gene transfer in haemophilia-Is more or less immunosuppression required?Edward G D Tuddenham, Graham R Foster
British Journal of Haematology|November 15, 2020
Haemophilia, the journey in search of a cure. 1960-2020Amit C Nathwani, Edward G D Tuddenham
Annals of Human Genetics|September 29, 2011
Human congenital diseases with mixed modes of inheritance have a shortage of recessive disease. A demographic scenario?N Avrion Mitchison, Shomi Bhattacharya, Edward G D Tuddenham
British Journal of Haematology|January 24, 2018
Recent advances in developing specific therapies for haemophiliaGavin Ling, Amit C Nathwani, Edward G D Tuddenham
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy for HemophiliaAmit C Nathwani, Andrew M Davidoff, Edward G D Tuddenham
Human Gene Therapy|August 25, 2017
Advances in Gene Therapy for HemophiliaAmit C Nathwani, Andrew M Davidoff, Edward G D Tuddenham
British Journal of Haematology|August 16, 2002
Use of a non-depleting anti-CD4 antibody to modulate the immune response to coagulation factors VIII and IXNina Salooja, Geoffrey Kemball-Cook, Edward G D Tuddenham, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|March 18, 2006
Ways to bypass a blocked tenase complexEdward G D Tuddenham
Blood|September 24, 2008
Killing 2 birds with 1 stoneEdward G D Tuddenham
British Journal of Haematology|January 5, 2020
Factor VIII: the protein, cloning its gene, synthetic factor and now - 35 years later - gene therapy; what happened in between?Gavin Ling, Edward G D Tuddenham
Journal of Viral Hepatitis|April 12, 2024
The complex, confusing and poorly understood immune responses to AAV-mediated gene transfer in haemophilia-Is more or less immunosuppression required?Edward G D Tuddenham, Graham R Foster
British Journal of Haematology|November 15, 2020
Haemophilia, the journey in search of a cure. 1960-2020Amit C Nathwani, Edward G D Tuddenham
Annals of Human Genetics|September 29, 2011
Human congenital diseases with mixed modes of inheritance have a shortage of recessive disease. A demographic scenario?N Avrion Mitchison, Shomi Bhattacharya, Edward G D Tuddenham
British Journal of Haematology|January 24, 2018
Recent advances in developing specific therapies for haemophiliaGavin Ling, Amit C Nathwani, Edward G D Tuddenham
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy for HemophiliaAmit C Nathwani, Andrew M Davidoff, Edward G D Tuddenham
Human Gene Therapy|August 25, 2017
Advances in Gene Therapy for HemophiliaAmit C Nathwani, Andrew M Davidoff, Edward G D Tuddenham
British Journal of Haematology|August 16, 2002
Use of a non-depleting anti-CD4 antibody to modulate the immune response to coagulation factors VIII and IXNina Salooja, Geoffrey Kemball-Cook, Edward G D Tuddenham, et al.
Pageof 5